Skip to content

INFINITY Fluid Management Accessory FG-0204Recalls & reported problems

Minerva Surgical, Inc. · Symphion Operative Hysteroscopy System, Fluid Management with filter for recirculation. For use with Symphion Controller. · Class 2

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00850033976236), received between May 23, 2025 and May 23, 2025 — classified as 1 injury.

The most frequently reported specific device problem is “Off-Label Use” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 1 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Off-Label Use1
  • Use of Device Problem1

Patient problems

  • Uterine Perforation1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMay 23, 2025Off-Label Use; Use of Device Problem; Off-Label Use; Use of Device Problem

    IT WAS REPORTED THAT A PATIENT TOOK ON APPROXIMATELY 3100ML OF FLUID AND WAS ADMITTED TO THE ICU. STAFF CALLED THE MINERVA REPRESENTATIVE AFTER A SECOND BAG WAS ADDED TO SYSTEM IN CONFLICT WITH THE PRESCRIBED LABELING. THE MINERVA REPRESENTATIVE INSTRUCTED THEM TO ACCOUNT FOR ALL FLUID OUTSIDE OF THE PATIENT AND STOP THE PROCEDURE IMMEDIATELY. ACCORDING TO THE TREATING RESIDENT, A PERFORATION WAS REPAIRED LAPAROSCOPICALLY AND THE PATIENT WAS SENT TO THE ICU OVERNIGHT FOR OBSERVATION. THERE WAS NO REPORTS OF SYMPTOMS RELATED TO FLUID OVERLOAD OR ANY ADDITIONAL MEDICAL INTERVENTION. PATIENT STATUS IS UNKNOWN BUT REPORTEDLY THE PATIENT WAS SCHEDULED TO BE RELEASED THE NEXT DAY.

    Patient problems: Uterine Perforation

    MAUDE report 22077165 ↗

Other Insufflator, Hysteroscopic, Fluid, Closed-Loop Recirculation With Cutter-Coagulator, Endoscopic, Bipolar devices

All Insufflator, Hysteroscopic, Fluid, Closed-Loop Recirculation With Cutter-Coagulator, Endoscopic, Bipolar devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page